2026
mon14sep11:00 am12:00 pmGastric Cancer Alliance Webinar11:00 am - 12:00 pm PST Online
Event Details
This educational program will provide an overview of HER2-positive gastric cancer, the role of biomarker testing in identifying eligible patients for targeted therapy, and emerging
Event Details
This educational program will provide an overview of HER2-positive gastric cancer, the role of biomarker testing in identifying eligible patients for targeted therapy, and emerging treatment advances that may help improve outcomes for those living with this disease.
During the webinar, participants will hear from a leading expert in gastrointestinal oncology who will discuss:
– The importance of HER2 biomarker testing in gastric cancer
– Current treatment approaches for HER2-positive disease
– New treatment options and clinical data
– Practical considerations for patients, caregivers, and healthcare teams
– Current treatment approaches for HER2-positive disease
– New treatment options and clinical data
– Practical considerations for patients, caregivers, and healthcare teams
This webinar is intended to support awareness and education within the gastric cancer community and provide advocacy organizations, patient navigators, and other stakeholders with information they can share with the patients and families they serve.
This webinar has passed: Watch the Recording
Time
(Monday) 11:00 am - 12:00 pm PST
Location
Online